Gastrointestinal perforation during primary hospitalisation · preventing bronchopulmonary dysplasia in preterm infants
Early systemic postnatal corticosteroids leads to higher gastrointestinal perforation during primary hospitalisation compared with placebo or no treatment (high certainty).
1 finding from 1 review
Cerebral palsy · preventing bronchopulmonary dysplasia in preterm infants
Early systemic postnatal corticosteroids leads to higher cerebral palsy at latest reported age compared with placebo or no treatment (high certainty).
1 finding from 1 review
Death or cerebral palsy · preventing bronchopulmonary dysplasia in preterm infants
Early systemic postnatal corticosteroids showed no clear difference in mortality or cerebral palsy at latest reported age compared with placebo or no treatment (high certainty).
1 finding from 1 review
Meters change from baseline in 6MWD · pulmonary arterial hypertension
1 finding from 1 review
Proportion of participants with improved functional class mean duration of study 16.8 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists probably leads to higher proportion of participants with improved functional class mean… compared with placebo (moderate certainty).
1 finding from 1 review
Change from baseline in BDI mean duration of study 14.3 weeks · pulmonary arterial hypertension
1 finding from 1 review
Mortality mean duration of study 30.2 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists showed no clear difference in mortality mean duration of study 30.2 weeks compared with placebo (low certainty).
1 finding from 1 review
Change from baseline in mean PAP (mmHg) mean duration of study 17.1 weeks · pulmonary arterial hypertension
1 finding from 1 review
Change from baseline in PVR (dyn/s/cm5) mean duration of study 15.7 weeks · pulmonary arterial hypertension
1 finding from 1 review
Hepatic toxicity mean duration of study 25 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists showed no clear difference in hepatic toxicity mean duration of study 25 weeks compared with placebo (moderate certainty).
1 finding from 1 review
Health‐related quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Functional exercise capacity · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Respiratory‐related hospital admissions · patients with chronic obstructive pulmonary disease
Integrated disease management interventions leads to lower respiratory‐related hospital admissions compared with usual care (high certainty).
1 finding from 1 review
Hospital admissions · patients with chronic obstructive pulmonary disease
Integrated disease management interventions probably leads to lower hospital admissions, all causes compared with usual care (moderate certainty).
1 finding from 1 review
Hospital days per patient, all causes · patients with chronic obstructive pulmonary disease
1 finding from 1 review
ED visits · patients with chronic obstructive pulmonary disease
Integrated disease management interventions probably leads to lower ED visits compared with usual care (moderate certainty).
1 finding from 1 review
Test result · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
False positives · adults with presumptive pulmonary tuberculosis Role: an initial test Index tests: Xpert Ultra and Xpert MTB/RIF Threshold for index tests:…
1 finding from 1 review
True positives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review
False negatives · adults with presumptive pulmonary tuberculosis. Participants were unselected, meaning they were not enrolled in a study based on…
1 finding from 1 review